Arcutis Announces Successful Phase 3 Results for Roflumilast Cream 0.05% in Children with Atopic Dermatitis
This new data results from the pivotal INTEGUMENT-PED trial and met both its primary and secondary endpoints.
Source: hcplive.com
Smitht Arcutis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Smitht Arcutis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Smitht Arcutis Today - Breaking & Trending Today